Cargando…

Proteomics and Drug Repurposing in CLL towards Precision Medicine

SIMPLE SUMMARY: Despite continued efforts, the current status of knowledge in CLL molecular pathobiology, diagnosis, prognosis and treatment remains elusive and imprecise. Proteomics approaches combined with advanced bioinformatics and drug repurposing promise to shed light on the complex proteome h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mavridou, Dimitra, Psatha, Konstantina, Aivaliotis, Michalis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8303629/ https://www.ncbi.nlm.nih.gov/pubmed/34298607 http://dx.doi.org/10.3390/cancers13143391

Ejemplares similares

Invariable Ribosome Stoichiometry During Murine Erythroid Differentiation: Implications for Understanding Ribosomopathies
por: Papagiannopoulos, Christos I., et al.
Publicado: (2022)

Subtyping on Live Lymphoma Cell Lines by Raman Spectroscopy
por: Katsara, Klytaimnistra, et al.
Publicado: (2022)

Emerging Therapies in CLL in the Era of Precision Medicine
por: Iyer, Prajish, et al.
Publicado: (2023)

Towards precision medicine for pain: diagnostic biomarkers and repurposed drugs
por: Niculescu, A. B., et al.
Publicado: (2019)

Interruption of p53-MDM2 Interaction by Nutlin-3a in Human Lymphoma Cell Models Initiates a Cell-Dependent Global Effect on Transcriptome and Proteome Level
por: Psatha, Konstantina, et al.
Publicado: (2023)

Proteomics in Childhood Acute Lymphoblastic Leukemia: Challenges and Opportunities
por: Kourti, Maria, et al.
Publicado: (2023)

Repurposing drugs to treat cardiovascular disease in the era of precision medicine
por: Abdelsayed, Mena, et al.
Publicado: (2022)

Towards precision medicine for anxiety disorders: objective assessment, risk prediction, pharmacogenomics, and repurposed drugs
por: Roseberry, K., et al.
Publicado: (2023)

Proteomics and peptidomics: moving toward precision medicine in urological malignancies
por: Meo, Ashley Di, et al.
Publicado: (2016)

Towards Precision Medicine for Osteoarthritis: Focus on the Synovial Fluid Proteome
por: Moretti, Lorenzo, et al.
Publicado: (2022)

Validating genomic tools for precision medicine in CLL: ERIC leads the way
por: Wiestner, Adrian
Publicado: (2021)

Personalized Proteomics: The Future of Precision Medicine
por: Duarte, Trevor T., et al.
Publicado: (2016)

Precision medicine for mood disorders: objective assessment, risk prediction, pharmacogenomics, and repurposed drugs
por: Le-Niculescu, H., et al.
Publicado: (2021)

Migration of Type III Secretion System Transcriptional Regulators Links Gene Expression to Secretion
por: Charova, Spyridoula N., et al.
Publicado: (2018)

“Hard” Drug Repurposing for Precision Oncology: The Missing Link?
por: Pantziarka, Pan, et al.
Publicado: (2018)

Towards Drug Repurposing in Cancer Cachexia: Potential Targets and Candidates
por: Santos, Joana M. O., et al.
Publicado: (2021)

Application of nanomaterials in proteomics-driven precision medicine
por: Zhang, Yong, et al.
Publicado: (2022)

Precision Editing as a Therapeutic Approach for β-Hemoglobinopathies
por: Paschoudi, Kiriaki, et al.
Publicado: (2023)

Toward precision medicine of breast cancer
por: Carels, Nicolas, et al.
Publicado: (2016)

Proteomic Characterization of Acute Myeloid Leukemia for Precision Medicine
por: Casado, Pedro, et al.
Publicado: (2023)

Male Infertility, Precision Medicine and Systems Proteomics
por: Agharezaee, Niloofar, et al.
Publicado: (2018)

Biocomputing drug repurposing toward targeted therapies
por: Cardone, Luca
Publicado: (2016)

Towards Precision Medicine in Systemic Lupus Erythematosus
por: Lever, Elliott, et al.
Publicado: (2020)

Proteomics advances towards developing SARS-CoV-2 therapeutics using in silico drug repurposing approaches
por: Mukherjee, Amrita, et al.
Publicado: (2021)

In Vitro and In Vivo Models of CLL–T Cell Interactions: Implications for Drug Testing
por: Hoferkova, Eva, et al.
Publicado: (2022)

Drugging the epigenome in the age of precision medicine
por: Feehley, Taylor, et al.
Publicado: (2023)

Current Treatment Options in CLL
por: Bewarder, Moritz, et al.
Publicado: (2021)

Toward precision medicine in inflammatory breast cancer
por: Viale, Giulia, et al.
Publicado: (2019)

Repurposing of approved cardiovascular drugs
por: Ishida, Junichi, et al.
Publicado: (2016)

Repurposed Drugs in Gastric Cancer
por: Araújo, Diana, et al.
Publicado: (2022)

Towards Building a Quantitative Proteomics Toolbox in Precision Medicine: A Mini-Review
por: Correa Rojo, Alejandro, et al.
Publicado: (2021)

Identifying Hub Genes Associated with Neoadjuvant Chemotherapy Resistance in Breast Cancer and Potential Drug Repurposing for the Development of Precision Medicine
por: Saha Detroja, Trishna, et al.
Publicado: (2022)

Towards Circulating-Tumor DNA-Based Precision Medicine
por: Hironaka-Mitsuhashi, Ai, et al.
Publicado: (2019)

Drug Repurposing for Schistosomiasis: Combinations of Drugs or Biomolecules
por: Gouveia, Maria João, et al.
Publicado: (2018)

Toward Precision Medicine in ADHD
por: Buitelaar, Jan, et al.
Publicado: (2022)

Towards precision medicine: Omics approach for COVID-19
por: Cen, Xiaoping, et al.
Publicado: (2023)

Critical molecular pathways in CLL therapy
por: Ferrer, Gerardo, et al.
Publicado: (2018)

Ibrutinib dose modifications in the management of CLL
por: Hardy-Abeloos, Camille, et al.
Publicado: (2020)

Precision Medicine and Adverse Drug Reactions Related to Cardiovascular Drugs †
por: Noyes, James D., et al.
Publicado: (2021)

Towards precision medicine for stress disorders: diagnostic biomarkers and targeted drugs
por: Le-Niculescu, H., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_a0jldd3ifmstuq10k9sm5cidvl